Alan Philips

Drug Development Advisory Board

Dr Philips provides statistical consultancy services to the Pharmaceutical Industry based on 35+ years of experience working in the Pharmaceutical and Clinical Research Organisation (CRO) industries. Alan has experience of regulatory submissions in many therapeutic areas such as Biosimilars (Rituximab, Herceptin), CNS (depression, insomnia, Generalized Anxiety Disorder), Cardiovascular (Hypertension), Oncology (Breast Cancer) and Womenโ€™s Health (Hormone Replacement Therapy, Oral Contraceptives). For example, Alan developed and justified the sample size and statistical analysis strategy for managing missing data for a biosimilar development program for the FDA. He have also recently provided statistical support for clinical development plans in Osteogenesis Imperfecta, Sarcopenia and Chronic active antibody-mediated rejection (AMR) in Kidney transplant recipients. He represents clients at FDA and EMA regulatory meetings, as well as being an expert statistical member on DMCs.

Get started with us today

Discover what’s possible when you have the right partner. Get in touch to see how we can support you.

Other board members

Got a question? Get in Touch or Submit an RFI/RFP


Our team is on hand to answer any questions you might have relating to the work we do at Simbec-Orion. Just fill in the form below, making sure to tick the boxes that apply, and weโ€™ll respond as quickly as we can.

Looking to volunteer for a clinical trial?

Visit our dedicated volunteer website here, or email [email protected]

Follow us on Social Media

Send us a message, weโ€™ll respond as quickly as possible

Complete the form below, and weโ€™ll get back to you as soon as possible regarding your query.

Name(Required)
Opt In Emails